Development of JCARH125 optimization of a fully human anti-Bcma CAR for use in the treatment of multiple myeloma

Kim Harrington, Rebecca Wu, Collin Hauskins, Rupesh Amin, Thomas Long, Aye Chen, Ayu Rahardjo, Casey Thayer, Garnet Navvaro, Madelyn Myers, Jon Jones, Alex Baturevych, Stan Morkowski, Ruth Salmon, Christopher J. Bond, Mette Stæhr, Terence J. Purdon, Reed Masakayan, Cheng Liu, Hong LiuYiang Xu, Pei Wang, Margot Pont, Damian J. Green, Reiner J. Brentjens, Eric L. Smith, Blythe Duke Sather

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
Artikelnummer1813
TidsskriftBlood
Vol/bind130
Udgave nummerSuppl. 1
Antal sider1
ISSN0006-4971
DOI
StatusUdgivet - 7. dec. 2017
Begivenhed59th AHS Annual Meeting - Atlanta, USA
Varighed: 9. dec. 201712. dec. 2017

Konference

Konference59th AHS Annual Meeting
LandUSA
ByAtlanta
Periode09/12/201712/12/2017

Citationsformater

Harrington, K., Wu, R., Hauskins, C., Amin, R., Long, T., Chen, A., Rahardjo, A., Thayer, C., Navvaro, G., Myers, M., Jones, J., Baturevych, A., Morkowski, S., Salmon, R., Bond, C. J., Stæhr, M., Purdon, T. J., Masakayan, R., Liu, C., ... Sather, B. D. (2017). Development of JCARH125 optimization of a fully human anti-Bcma CAR for use in the treatment of multiple myeloma. Blood, 130(Suppl. 1), [1813]. https://doi.org/10.1182/blood.V130.Suppl_1.1813.1813